

Diltiazem
| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.37 | $101.00 (0%) | 🛒 Add to cart |
| 60 | $2.70 | $202.00 $162.00 (20%) | 🛒 Add to cart |
| 90 | $2.49 | $303.00 $224.00 (26%) | 🛒 Add to cart |
| 120 | $2.37 | $404.00 $284.00 (30%) | 🛒 Add to cart |
| 180 | $2.26 | $606.00 $406.00 (33%) | 🛒 Add to cart |
| 270 | $2.19
Best per pill | $909.00 $590.00 (35%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.00 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $73.50 $70.00 (5%) | 🛒 Add to cart |
| 120 | $0.76 | $98.00 $91.00 (7%) | 🛒 Add to cart |
| 180 | $0.73 | $147.00 $132.00 (10%) | 🛒 Add to cart |
| 270 | $0.72 | $220.50 $195.00 (12%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $294.00 $257.00 (13%) | 🛒 Add to cart |
Similar products

More info:
Atorlip 10: Effective LDL Cholesterol Management for Cardiovascular Health
Atorlip 10 is a prescription medication containing atorvastatin calcium, a potent lipid-lowering agent belonging to the statin class. It is specifically formulated to reduce elevated levels of low-density lipoprotein (LDL) cholesterol, triglycerides, and apolipoprotein B, while moderately increasing high-density lipoprotein (HDL) cholesterol in adult patients. Clinical evidence supports its role in primary and secondary prevention of cardiovascular events, including myocardial infarction and stroke, particularly in individuals with multiple risk factors or established coronary heart disease.
Atorlip 20: Advanced Cholesterol Management for Cardiovascular Health
Atorlip 20 is a prescription medication containing atorvastatin calcium, a potent lipid-lowering agent classified as an HMG-CoA reductase inhibitor (statin). It is specifically formulated to reduce elevated levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, apolipoprotein B, and triglycerides in the blood, while increasing high-density lipoprotein (HDL) cholesterol. By targeting the hepatic synthesis of cholesterol, Atorlip 20 plays a critical role in the primary and secondary prevention of cardiovascular events, including myocardial infarction and stroke, in appropriate patient populations.
Atorlip 5: Effective Cholesterol Management for Cardiovascular Health
Atorlip 5 contains atorvastatin calcium, a potent lipid-lowering medication belonging to the statin class. It is indicated as an adjunct to diet and lifestyle modifications for the management of dyslipidemia, specifically to reduce elevated levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B. By competitively inhibiting HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis, Atorlip 5 enhances the clearance of circulating LDL via upregulation of hepatic LDL receptors.
Zocor: Proven Cholesterol Control for Cardiovascular Health
Zocor (simvastatin) is a widely prescribed, HMG-CoA reductase inhibitor (statin) medication trusted by healthcare professionals for decades. It functions by effectively reducing the production of “bad” cholesterol (LDL) and triglycerides in the liver while moderately increasing levels of “good” cholesterol (HDL). This targeted action is clinically proven to slow the progression of atherosclerosis, significantly lowering the risk of major cardiovascular events such as heart attacks and strokes in at-risk patients. Its established efficacy and extensive safety profile make it a cornerstone in preventive cardiology and long-term lipid management strategies.
Abana: Natural Cardiovascular Support for Optimal Heart Health
Abana is a clinically studied, multi-herbal formulation designed to support cardiovascular wellness and maintain healthy cholesterol levels already within the normal range. This expert-formulated supplement combines time-tested Ayurvedic herbs with modern pharmacological understanding to provide a holistic approach to heart health. It functions by promoting healthy lipid metabolism, supporting arterial elasticity, and providing antioxidant protection against oxidative stress. For individuals seeking a natural adjunct to a heart-healthy lifestyle, Abana offers a scientifically grounded option backed by traditional use and contemporary research.
Accupril: Effective Blood Pressure Control for Cardiovascular Health
Accupril (quinapril hydrochloride) is an angiotensin-converting enzyme (ACE) inhibitor prescription medication specifically formulated for the management of hypertension and heart failure. As a frontline therapeutic agent, it works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing peripheral arterial resistance. This mechanism of action makes it a cornerstone in cardiovascular risk reduction strategies, particularly for patients requiring comprehensive blood pressure management alongside other cardiovascular conditions.
Actigall: Effective Dissolution Therapy for Gallstones
Actigall (ursodiol) is a bile acid medication specifically formulated to dissolve certain types of gallstones in patients for whom surgery poses an unacceptable risk. It works by reducing the cholesterol saturation of bile, thereby promoting the gradual dissolution of radiolucent, non-calcified cholesterol stones in a functioning gallbladder. This oral therapy represents a non-surgical alternative for a carefully selected patient population, offering a targeted approach to managing symptomatic gallstone disease under expert medical supervision.
Actonel: Clinically Proven to Increase Bone Mineral Density
Actonel (risedronate sodium) is a bisphosphonate medication specifically formulated for the treatment and prevention of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. It works by inhibiting osteoclast-mediated bone resorption, thereby slowing bone loss, reducing the risk of fractures, and promoting a positive bone remodeling balance. This oral tablet is a cornerstone of pharmacological management for bone density conditions, offering a well-tolerated profile with proven long-term efficacy in maintaining skeletal integrity.
Aggrenox: Dual-Antiplatelet Protection Against Recurrent Stroke
Aggrenox is a prescription medication specifically formulated to reduce the risk of recurrent ischemic stroke in patients who have experienced a prior stroke or transient ischemic attack (TIA). It combines two active antiplatelet agents—aspirin and dipyridamole—in an extended-release formulation designed to work synergistically. This combination therapy targets distinct pathways of platelet aggregation, offering a comprehensive approach to secondary stroke prevention. By inhibiting clot formation through complementary mechanisms, Aggrenox provides a robust therapeutic option backed by clinical evidence demonstrating significant risk reduction compared to monotherapy approaches.